- Presentations
- 5
- Markets
- 1
Subvenite is a brand of Lamotrigine marketed by OWP Pharmaceuticals, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lamotrigine
- Brand owner
- OWP Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 10 mg/mL oral suspension, 100 mg tablet, 150 mg tablet, 200 mg tablet, 25 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Subvenite 10 mg/mL oral suspensionOral | OWP Pharmaceuticals | US FDA | Available on request |
| Subvenite 100 mg tabletOral | OWP Pharmaceuticals | US FDA | Available on request |
| Subvenite 150 mg tabletOral | OWP Pharmaceuticals | US FDA | Available on request |
| Subvenite 200 mg tabletOral | OWP Pharmaceuticals | US FDA | Available on request |
| Subvenite 25 mg tabletOral | OWP Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Lamotrigine.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Subvenite
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.